Bergfeld W, Et Al. Double-Blind, Randomized, Placebo-Controlled Trial Of The Efficacy And Safety Of 5% Minoxidil Foam 04 February 2005. Based On The 2022 Dermatologist Recommendation Study Conducted By Ipsos Healthcare, Rogaine Is The #1 Recommended Otc Hair Regrowth Brand. Bland He, Kupiecki Rm, Sinkula Ms. Efficacy Comparison Of 5% Minoxidil Solution, Rogaine Topical Solution And Placebo In Male Pattern Baldness. Upjohn Technical Report 9157-91-028, August 23, 1991 (Revised October 24, 1994 & October 27, 1995). Price Vh, Menefree E, Strauss Pc. Changes In Hair Weight And Hair Count In Men With Androgenetic Alopecia, After Application Of 5% And 2% Topical Minoxidil, Placebo, Or No Treatment. J Am Acad Dermatol.1999;41:717-721. Rogaine Ask Suzy Survey Fielded To 224 Total Participating Males With Stage 2 Hair Loss Or Greater, Ages 18-54, Fielded From Oct 31-Nov 14, 2023.
Actual product packaging and materials may contain more and/or different information than that shown on our website. We recommend that you do not solely rely on the information presented and that you always read labels, warnings, and directions before using or consuming a product.
For additional information about a product, please contact the manufacturer. Content on this site is for reference purposes and is not intended to substitute for advice given by a physician, pharmacist, or other licensed health-care professional. ZiFiti does not assume liability for inaccuracies or misstatements about products.
Statements regarding dietary supplements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease or health condition.
